Thomas Massie actually said...

If companies couldn't recover their cost? That should be a fairly simple question to answer.

The U.S. Congress shall have power to promote the progress of science and useful arts by securing, for limited times, to authors and invento...

Biopharmaceutical companies are far outspending the Federal Government for R&D for cures for various diseases.

Democrats have chosen to discard months of bipartisan work and conduct this partisan hearing to attack companies that are working to help th...